CHEMOMAB THERAPEUTICS LTD (CMMB) Forecast, Price Target & Analyst Ratings

NASDAQ:CMMB • US16385C2035

Current stock price

1.67 USD
-0.01 (-0.6%)
At close:
1.67 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CHEMOMAB THERAPEUTICS LTD (CMMB).

Forecast Snapshot

Consensus Price Target

Price Target
$15.30
+ 816.17% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$15.30
Upside
+ 816.17%
From current price of $1.67 to mean target of $15.30, Based on 8 analyst forecasts
Low
$5.05
Median
$15.30
High
$26.25

Price Target Revisions

1 Month
-14.29%
3 Months
-43.40%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for CMMB. The average price target is 15.3 USD. This implies a price increase of 816.17% is expected in the next year compared to the current price of 1.67.
The average price target has been revised downward by 43.4% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CMMB Current Analyst RatingCMMB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CMMB Historical Analyst RatingsCMMB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Analyst Ratings Consensus

ChartMill Buy Consensus
85.00%
CMMB was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about CMMB.
In the previous month the buy percentage consensus was at a similar level.
CMMB was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-08-27OppenheimerMaintains Outperform -> Outperform
2025-05-16OppenheimerMaintains Outperform -> Outperform
2025-02-20Maxim GroupMaintains Buy -> Buy
2024-11-15OppenheimerReiterate Outperform -> Outperform
2024-05-13Maxim GroupInitiate Buy
2024-05-06OppenheimerUpgrade Perform -> Outperform
2024-03-08OppenheimerMaintains Perform -> Perform
2023-12-19Roth MKMReiterate Buy
2023-10-06Roth MKMInitiate Buy
2023-06-07OppenheimerDowngrade Outperform -> Perform
2023-04-18OppenheimerMaintains Outperform
2022-03-10OppenheimerMaintains Outperform
2021-12-07Aegis CapitalInitiate Buy
2021-05-26Cantor FitzgeraldInitiate Overweight
2021-05-07OppenheimerInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 13, 2026
Period
Q1 / 2026
EPS Estimate
-$0.16
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
71.77%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
-1,450.00%
EPS (3 Months)
-1,450.00%

Next Earnings Summary

CMMB is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -0.16 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CMMB revenue by date.CMMB revenue by date.
N/AN/AN/AN/AN/AN/A
221.30%		N/A
280.12%		N/A
80.49%		N/A
30.64%
EBITDA
YoY % growth
CMMB ebitda by date.CMMB ebitda by date.
-19.27M-10.94M
43.23%		-12.34M
-12.80%		-28.47M
-130.71%		-25.392M
10.81%		-14.686M
42.16%		-9.497M
35.33%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CMMB ebit by date.CMMB ebit by date.
-19.55M-10.96M
43.94%		-12.37M
-12.86%		-28.53M
-130.64%		-25.459M
10.76%		-14.739M
42.11%		-9.567M
35.09%		N/A
-127.16%		N/A
-16.52%		N/A
-22.52%		N/A
55.17%		N/A
423.58%		N/A
172.79%		N/A
111.35%		N/A
35.89%
Operating Margin
CMMB operating margin by date.CMMB operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
CMMB eps by date.CMMB eps by date.
-252.80N/A-4.72-9.64
-104.24%		N/A
98.73%		-2.76
-2,154.90%		N/A
43.46%		N/A
5.23%		N/A
14.48%		N/A
3.23%		N/A
83.33%		N/A
-20.00%		N/A
866.67%		N/A
58.70%		N/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.16
71.77%		-0.07
-600.00%		-0.13
-1,150.00%		-0.14
42.62%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		-3.636M
-4.28%		-3.865M
-70.88%		-4.323M
-134.45%		-4.425M
-124.15%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CMMB Yearly Revenue VS EstimatesCMMB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2029 2030 2031 2032 2033 100M 200M 300M 400M 500M
CMMB Yearly EPS VS EstimatesCMMB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -50 -100 -150 -200 -250

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.52%
EPS Next 5 Year
14.01%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

CHEMOMAB THERAPEUTICS LTD / CMMB Forecast FAQ

What do analysts expect the price target to be for CHEMOMAB THERAPEUTICS LTD (CMMB)?

8 analysts have analysed CMMB and the average price target is 15.3 USD. This implies a price increase of 816.17% is expected in the next year compared to the current price of 1.67.

Can you provide the upcoming earnings date for CHEMOMAB THERAPEUTICS LTD?

CHEMOMAB THERAPEUTICS LTD (CMMB) will report earnings on 2026-05-13.

What are the consensus estimates for CHEMOMAB THERAPEUTICS LTD (CMMB) next earnings?

The consensus EPS estimate for the next earnings of CHEMOMAB THERAPEUTICS LTD (CMMB) is -0.16 USD and the consensus revenue estimate is 0 USD.

How many analysts have analysed CHEMOMAB THERAPEUTICS LTD (CMMB)?

The number of analysts covering CHEMOMAB THERAPEUTICS LTD (CMMB) is 8.